#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Erdheim-Chester disease Neoplasm malignant Netherton's syndrome Myelodysplastic syndrome Blood iron increased Herpes simplex Short stature Toxic epidermal necrolysis Enteritis Thrombotic thrombocytopenic purpura Leukoencephalopathy Juvenile psoriatic arthritis Blastic plasmacytoid dendritic cell neoplasia Congenital growth hormone deficiency Diffuse large B-cell lymphoma refractory More trials…

    Learn about Rare Diseases

    Glycogen storage disease type II Hepatic angiosarcoma Angiosarcoma metastatic – Diagnostics Focal segmental glomerulosclerosis – Life with Disease Von Willebrand’s disease – Life with Disease Mucopolysaccharidosis – Life with Disease Gastrointestinal stromal tumour – Diagnostics Proteus syndrome – Basic Information Lennox-Gastaut syndrome Antisynthetase syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Metamizole Narsoplimab IMELASOMERAN Canakinumab Apocynin AUROCELL-TX ANXV ICEF15 Aspartic Acid Interleukin-2 Testosterone Timbetasin Acetate Mepolizumab Vindesine Sulfate Zanamivir Clemastine Fumarate Redasemtide Messenger Rna Encoding Cas9 AZD0516 Ab-1002 More therapies…

    Learn about Your Condition

    Familial mediterranean fever Leukocyte adhesion deficiency Nocturia Head and neck cancer stage III Endocarditis Necrotising myositis Polymyalgia rheumatica Oesophageal achalasia Plasma cell myeloma recurrent Anxiety disorder Infertility female Endocrine ophthalmopathy Haemoptysis Cholangitis sclerosing Juvenile psoriatic arthritis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on Reducing Eye Prosthesis Discomfort and Discharge Using Retinol Palmitate, Fluorometholone, and Artificial Tears for Patients with Chronic Eye Socket Issues

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Eye inflammation
    Investigated Drugs:
    • Fluorometholone
    • Sodium Hyaluronate
    • Retinol Palmitate
    The Netherlands

  • Study on the Effect of Xylometazoline Nasal Spray on Physical Capacity in Adults with Chronic Obstructive Pulmonary Disease (COPD)

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic obstructive pulmonary disease
    Investigated Drugs:
    • XYLOMETAZOLINE HYDROCHLORIDE
    Norway

  • Study on Using Perflubutane in Ultrasound Imaging for Patients Needing Lymphatic Imaging

    Not yet recruiting

    4 1 1 1
    Investigated Drugs:
    • Perflubutane
    Finland

  • Study of ropivacaine, sodium chloride and gadoteric acid in nerve blocks for hip pain in healthy volunteers

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Pain in extremity
    Investigated Drugs:
    • Ropivacaine Hydrochloride
    • Gadoteric Acid
    • Sodium Chloride
    Denmark

  • Study on Thiethylperazine and Florbetaben (18F) for Early Alzheimer’s Disease Patients

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    • Florbetaben (18F)
    Germany

  • Study on the Effects of AD04 and Placebo in Patients with Early Alzheimer’s Disease

    Not yet recruiting

    2 1
    Investigated Drugs:
    • Aluminium Hydroxide
    Austria Poland
Previous Page
1 … 802 803 804 805 806 … 1,673
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!